The healthcare landscape is witnessing a change with the arrival of GLP-1 delivery devices. These innovative formulations offer a promising alternative to delivering glucagon-like peptide-1 drugs for individuals living with the disease . Instead of injections , a simple patch affixed to the skin could release a steady amount of the treatment , poss